Turn Therapeutics TTRX
NASDAQ TTRX
$10.47 -0.27 (-2.51%)
At close: Oct 20, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Net Cash Flow (2024 - 2026)

Updated

Turn Therapeutics' Net Cash Flow came in at -$972,990 for Q2 2026, compared with $1.65 million a year earlier.

Analysis

Turn Therapeutics (TTRX) Net Cash Flow (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Turn Therapeutics reported Net Cash Flow of $7.02 million; for FY2025, it was $4.17 million.

  • Going back by year, Net Cash Flow was -$308,398 in FY2024.
  • Business Quant data shows TTRX's Net Cash Flow at $6.14 million (Q1 2026), $1.94 million (Q4 2025) and -$87,153 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.72 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -1.27 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -2.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 1.53 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 757.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -3.94 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 1.95 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -4.43 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -722.00 Mn
10 Turn Therapeutics 310.39 Mn 283.50 Mn - -972,990.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -972,990.00
Mar 31, 2026 6.14 Mn
Dec 31, 2025 1.94 Mn
Sep 30, 2025 -87,153.00
Jun 30, 2025 1.65 Mn
Mar 31, 2025 700,034.00
Dec 31, 2024 83,819.00
API Access

Turn Therapeutics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=TTRX&period=max&api_key=YOUR_API_KEY